Valuation
Orthopedic, Prosthetic & Surgical Appliances & SuppliesLive · Yahoo FinancePrice
$25.00
52-Week Range
Decision Context
Scores are balanced across the six engines. No single dimension dominates — this is consistent with a stable, mid-tier quality business.
Based on filing period ending Mar 2026
FisclearScore is a quantitative model using public financial data and sector median benchmarks (refreshed monthly). Not financial advice. Always conduct independent due diligence.
Macro Context
SWOT Analysis — AVNS
Inflationary BoomStrengths
EPS (Diluted): $-1.57 (+81.6% YoY) — Negative EPS — the company recorded a loss on a per-share basis.
Net Income: -$72.9M (+81.4% YoY) — The company posted a net loss — total expenses exceeded total revenue.
Weaknesses
Operating Cash Flow: $74.7M (-25.8% YoY) — Operating cash flow fell 26% but remained positive.
Gross Profit: $353.9M (-7.2% YoY) — Gross profit declined 7% — costs are growing faster than revenue.
Total Assets: $1.1B (-7.0% YoY) — Total assets shrank 7% — the balance sheet contracted.
Gross margin narrowed by 5.0pp — worth monitoring for further cost pressure.
Stock is near its 52-week high (24.91) — the price reflects strong recent momentum, but entry risk is elevated at these levels.
Opportunities
No clear opportunities identified at this time.
Threats
Net loss of $72.9M — the company spent more than it earned. Investors should monitor the path to profitability.
Financial Charts
Revenue vs Net Income
Gross Profit vs Operating Income
Margin Trend
Operating Cash Flow
Year-over-Year Changes
EPS (Diluted)
$-1.57
was $-8.53
Negative EPS — the company recorded a loss on a per-share basis.
Net Income
-$72.9M
was -$392.1M
The company posted a net loss — total expenses exceeded total revenue.
Operating Cash Flow
$74.7M
was $100.7M
Operating cash flow fell 26% but remained positive.
Gross Profit
$353.9M
was $381.3M
Gross profit declined 7% — costs are growing faster than revenue.
Total Assets
$1.1B
was $1.2B
Total assets shrank 7% — the balance sheet contracted.
Risk Flags
1 high · 0 medium · 2 low- ⚠ High
Net loss of $72.9M — the company spent more than it earned. Investors should monitor the path to profitability.
- ○ Low
Gross margin narrowed by 5.0pp — worth monitoring for further cost pressure.
- ○ Low
Stock is near its 52-week high (24.91) — the price reflects strong recent momentum, but entry risk is elevated at these levels.
Price History
Technical Signals
Daily closes · 1-year dataLatest News
via FinnhubGet the weekly digest
5 company reports + macro context every week, free. No spam.
- Unlimited goal simulations
- 5 free company report summaries per day
- Weekly financial insights newsletter
External Links
Trade AVNS
Links open broker research pages. Not an endorsement or recommendation.
Research AVANOS MEDICAL, INC.
Data sourced from SEC EDGAR, FRED (Federal Reserve Economic Data), and Yahoo Finance. For informational purposes only. Not financial advice.